Versant Venture Management

Venture Capital Exempt reporting adviser

Legal name: Versant Venture Management, LLC

San Francisco, CA Website

AUM

$3.9B
Private fund assets

Private funds

28
Venture Capital 28

Private fund assets

$3.9B
Gross asset value

Employees

—

Last Form D raise

Apr 2023
Most recent fund filing

From SEC Form ADV filing (filed Mar 30, 2026). View on SEC

Investment focus

As listed in industry directories; may be out of date.

Stages
Series AGrowth
Sectors
Life Sciences & Healthtech
Geographies
USACanadaSwitzerland

People(16)

Owners and executive officers named on the firm's SEC Form ADV.

A
Alexander Mayweg
Managing Director, Versant Ventures (switzerland) Gmbh
Source: SEC Form ADV
B
Barbara Lubash
Managing Member, Versant Venture Management, LLC
Source: SEC Form ADV
B
Bradley Bolzon
Managing Member, Versant Venture Management, LLC
Source: SEC Form ADV
B
Brian Atwood
Managing Member, Versant Venture Management, LLC
Source: SEC Form ADV
C
Carlo Rizzuto
Managing Member, Versant Vantage III Gp-Gp, LLC
Source: SEC Form ADV
C
Charles Warden
Managing Member, Versant Venture Management, LLC
Source: SEC Form ADV
C
Clare Ozawa
Managing Member, Versant Ventures VII Gp-Gp, LLC
Source: SEC Form ADV
D
Donald Milder
Managing Member, Versant Venture Management, LLC
Source: SEC Form ADV
J
Jerel Davis
Managing Member, Versant Ventures VII Gp-Gp, LLC
Source: SEC Form ADV
K
Kirk Nielsen
Managing Member, Versant Venture Management, LLC
Source: SEC Form ADV
M
Markus Enzelberger
Director of Versant Ventures (switzerland) Gmbh
Source: SEC Form ADV
R
Robin Praeger
Managing Member, Versant Venture Management, LLC
Source: SEC Form ADV

Funds(28)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Versant Venture Capital IX, L.P.Venture Capital$586.2M$600.4M82Apr 2023Cold
Versant Voyageurs III, L.P.Venture Capital$311.8M$300.2M82Apr 2023Cold
Versant Vantage III, L.P.Venture Capital$295.6M$298.7M82Apr 2023Cold
Versant Venture Capital VIII, L.P.Venture Capital$886.9M$560.2M87Apr 2021Cold
Versant Vantage II, L.P.Venture Capital$249.7M$253.9M52Apr 2021Cold
Versant Voyageurs II, L.P.Venture Capital$169.0M$140.1M87Apr 2021Cold
Versant Voyageurs I, L.P.Venture Capital$87.8M$102.2M14Aug 2019Cold
Versant Vantage I, L.P.Venture Capital$69.9M——Mar 2019Cold
Versant Venture Capital VII, L.P.Venture Capital$676.7M$600.0M74Dec 2018Cold
Versant Venture Capital VI, L.P.Venture Capital$275.9M$400.0M57Jan 2017Cold
Versant Venture Capital V, L.P.Venture Capital$134.9M$295.5M86Jun 2014Cold
Versant Side Fund II, L.P.Venture Capital$1.2M$3.6M16Mar 2012Cold
Versant Venture Capital IV, L.P.Venture Capital$38.4M———
Versant Voyageurs I Parallel, L.P.Venture Capital$26.7M———
Versant Venture Capital VIII (canada), L.P.Venture Capital$12.9M———

Board seats(5)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

Tempest Therapeutics
Other Health CareSouth San Francisco, CADirector: Bradley Bolzon
$83.2M raised
Since Mar 2018
SEC Form D
Oyster Point Pharma
PharmaceuticalsPrinceton, NJDirector: William Link
$113.6M raised
Since Oct 2017
SEC Form D
Rennovia
Other TechnologySanta Clara, CADirector: Samuel Colella
$36.3M raised
Since Feb 2017
SEC Form D
Audentes Therapeutics
BiotechnologySan Francisco, CADirector: Thomas Woiwode
$107.5M raised
Since Dec 2014
SEC Form D
Kanyos Bio
BiotechnologySan Francisco, CADirector: Thomas Woiwode
$16.4M raised
Since Jun 2015
SEC Form D

Shares boards with

Firms whose people sit on the same company boards.

Stamos Capital Partners
Asset Manager
1 shared

Regulatory identifiers

CRD number
161130
SEC file number
802-75823
CIK
1560009

Sources